QRG Capital Management’s GSK GSK Stock Holding History

QRG Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Buy	191,512 +13,519	+8%	+$715K	0.08%	203
2026 Q1	$9.82M	Buy	177,993 +33,462	+23%	+$1.81M	0.1%	180
2025 Q4	$7.09M	Buy	144,531 +28,324	+24%	+$1.32M	0.08%	207
2025 Q3	$5.02M	Sell	116,207 -33,949	-23%	-$1.33M	0.06%	239
2025 Q2	$5.77M	Buy	150,156 +3,505	+2%	+$134K	0.05%	291
2025 Q1	$5.68M	Sell	146,651 -10,645	-7%	-$390K	0.06%	283
2024 Q4	$5.32M	Sell	157,296 -31,812	-17%	-$1.15M	0.05%	281
2024 Q3	$7.73M	Sell	189,108 -6,259	-3%	-$256K	0.08%	212
2024 Q2	$7.52M	Buy	195,367 +14,202	+8%	+$597K	0.09%	205
2024 Q1	$7.77M	Buy	181,165 +39,751	+28%	+$1.64M	0.1%	203
2023 Q4	$5.24M	Buy	141,414 +23,578	+20%	+$846K	0.08%	248
2023 Q3	$4.27M	Buy	+117,836	New	+$4.18M	0.07%	252

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

QRG Capital Management's GSK Position: Q2 2026 in Review

QRG Capital Management increased its GSK (GSK) stake by 7.6% in Q2 2026, buying an estimated $715K and bringing the position to 191,512 shares worth $10M. The position accounts for 0.08% of the portfolio, ranked #203.

QRG Capital Management first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

QRG Capital Management held 191,512 shares of GSK worth $10M as of Q2 2026.
QRG Capital Management bought 13,519 GSK shares in Q2 2026, an estimated $715K.
GSK made up 0.08% of QRG Capital Management's portfolio in Q2 2026, its #203 holding.
QRG Capital Management first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.